Peripheral Neuropathic Pain - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Peripheral Neuropathic Pain -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Peripheral Neuropathic Pain in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Peripheral Neuropathic Pain. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Peripheral Neuropathic Pain. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Peripheral Neuropathic Pain sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Peripheral Neuropathic Pain market.

  • Identifying prevalent patient populations as well as risk factors in the global Peripheral Neuropathic Pain market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Peripheral Neuropathic Pain therapeutics in each of the markets covered.

Peripheral Neuropathic Pain - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Peripheral Neuropathic Pain Overview
Peripheral Neuropathic Pain Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Peripheral Neuropathic Pain

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Peripheral Neuropathic Pain
Sex-Specific Prevalent/Incident Cases of Peripheral Neuropathic Pain
Disease Type Specific Prevalent/Incident Cases of Peripheral Neuropathic Pain

8.Prevalent & Incident Cases by 7 MM-2015-2025
Peripheral Neuropathic Pain Epidemiology of United States-2025
Peripheral Neuropathic Pain Epidemiology of United Kingdom-2025
Peripheral Neuropathic Pain Epidemiology of Germany-2025
Peripheral Neuropathic Pain Epidemiology of France-2025
Peripheral Neuropathic Pain Epidemiology of Spain-2025
Peripheral Neuropathic Pain Epidemiology of Italy-2025
Peripheral Neuropathic Pain Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Peripheral Neuropathic Pain Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Peripheral Neuropathic Pain Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Peripheral Neuropathic Pain Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Peripheral Neuropathic Pain Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Peripheral Neuropathic Pain Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Peripheral Neuropathic Pain Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Peripheral Neuropathic Pain Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Peripheral Neuropathic Pain Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Peripheral Neuropathic Pain Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Peripheral Neuropathic Pain Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Peripheral Neuropathic Pain Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Peripheral Neuropathic Pain Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Peripheral Neuropathic Pain Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Peripheral Neuropathic Pain Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Peripheral Neuropathic Pain Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Peripheral Neuropathic Pain (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Peripheral Neuropathic Pain By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Peripheral Neuropathic Pain Sub-population,Japan (2015-2025)
  • Restless Legs Syndrome - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 47
    Restless Legs Syndrome - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome - Pipeline Review, H1 2018, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape. Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a disorder of the part of the nervous system that affects the legs and causes an urge to move......
  • Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 127
    Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2018, provides an overview of the Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline landscape. Post-traumatic stress disorder (PTSD) is a mental health condition that's triggered by a terrifying event either experienci......
  • Traumatic Brain Injury - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 270
    Traumatic Brain Injury - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H1 2018, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape. Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or ......
  • Tourette Syndrome - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 82
    Tourette Syndrome - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tourette Syndrome - Pipeline Review, H1 2018, provides an overview of the Tourette Syndrome (Central Nervous System) pipeline landscape. Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. Symptoms include eye blinking and othe......
  • Autism - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 169
    Autism - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Autism - Pipeline Review, H1 2018, provides an overview of the Autism (Central Nervous System) pipeline landscape. Autism, also known as complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication and repetitive behaviors. Risk factors include child's se......
  • Alcohol Addiction - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 134
    Alcohol Addiction - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alcohol Addiction - Pipeline Review, H1 2018, provides an overview of the Alcohol Addiction (Central Nervous System) pipeline landscape. Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decreased involvement in extracurricular activities, depression, restlessness, inabili......
  • Encephalitis - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 34
    Encephalitis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalitis - Pipeline Review, H1 2018, provides an overview of the Encephalitis (Central Nervous System) pipeline landscape. Encephalitis is an inflammation of the brain tissue. There are two main types of encephalitis: primary and secondary. Primary encephalitis occurs when a virus directly infects the brain and spinal c......
  • Drug Addiction - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 164
    Drug Addiction - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2018, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving ......
  • Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 39
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple System Atrophy - Pipeline Review, H2 2017, provides an overview of the Multiple System Atrophy (Central Nervous System) pipeline landscape. Multiple system atrophy (MSA) or Shy-Drager syndrome is a neurological disorder that impairs body's involuntary functions (blood pressure, heart rate, bladder function and digestion). Symptoms include rigid muscles, bradykinesia, Tremors, dysarthria, d......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs